Nanoplasmas

Nanoplasmas

Nanoplasmas is a spin-out company of NCSR Demokritos. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$600—900k (Dealroom.co estimates Apr 2019.)
Municipality of Agia Paraskevi Attica (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout

$150k

Early VC

$360k

Seed
Total Funding$510k

Recent News about Nanoplasmas

Edit
More about Nanoplasmasinfo icon
Edit

Nanoplasmas is a spin-off company from NCSR Demokritos specializing in advanced surface engineering and nanotechnology solutions. The company develops high-end consumables for health, food safety, agricultural, and environmental applications. Their core products include molecular detection kits for SARS-CoV-2 and Legionella, designed for use on surfaces, in HVAC systems, and in water samples. These kits utilize a simple color change initiated by an isothermal amplification reaction of genetic material, providing rapid and accurate results within two hours.

Nanoplasmas serves a diverse range of clients, including healthcare providers, food safety inspectors, agricultural businesses, and environmental agencies. Operating primarily in the biotechnology and nanotechnology markets, the company employs a business model centered around the sale of its patented detection kits and related reagents. Revenue is generated through direct sales, private funding rounds, and research grants, including support from the European Regional Development Fund and Greek national funds.

Keywords: nanotechnology, molecular detection, SARS-CoV-2, Legionella, health safety, food safety, environmental monitoring, rapid diagnostics, isothermal amplification, surface engineering.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.